Clinical trial
Phase I Study of MOC31-PE in Antigen Positive Carcinomas
NCT01061645 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study of MOC31-PE in Antigen Positive Carcinomas
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- February 29, 2012
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.